Coronavirus

New virus-based vaccines could play an important role in generating a long-lasting, broad immunity against a rapidly mutating virus.

Moderna expects to have an Omicron booster that combines its original COVID-19 vaccine with one targeting the variant ready by Fall 2022.

Moderna has asked the FDA to authorize its COVID-19 vaccine for children ages 6 months through 5 years.

So far, Test to Treat has largely failed to get antivirals for COVID-19 to patients that need them — but the initiative can still be fixed.

WeChat users have turned to all manner of tricks in a cat-and-mouse game with CCP censors to keep a video about the Shanghai lockdown online.

Philadelphia doctors are treating COVID patient’s loss of smell with plasma-soaked sponges. But whether it is working or not still needs to be sniffed out.

Far-UVC light — a type of ultraviolet light that isn’t harmful to human health — killed 98% of airborne microbes indoors in a new study.

A man whose persistent coronavirus infection kept him isolated for 7 months finally tested negative after receiving a COVID-19 vaccine.

In-development COVID-19 drug Peginterferon Lambda reduced risk of hospitalization or lengthy emergency room visits by 50% in a phase 3 trial.

China’s “zero-COVID” policies may be contributing to a surge of cases that has forced 50 million people into lockdown.